Dencichin, formerly known as β-ODAP, has been shown to alleviate metabolism disorder, improve renal function, relieve pathological alterations in the glomerulus of diabetic neuropathy in rats, decrease extracellular matrix deposition and increase the ratio of matrix metalloproteinase (MMP)-9 to tissue inhibitor of metalloproteinase (TIMP)-1 both in vivo and in vitro. References: Fu C, Liu S, Li Z. [Determination of dencichine in sanchi using liquid chromatography on porous graphitic carbon column]. Se Pu. 2007 Nov;25(6):834-7. Chinese. PubMed PMID: 18257299.

纯度：≥98%

CAS：5302-45-4